Stay updated on Oral Gallium Maltolate for Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.

Latest updates to the Oral Gallium Maltolate for Glioblastoma Clinical Trial page
- Check7 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected study details, indicating an access or server issue that prevents viewing the entry.SummaryDifference19%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays a new revision number (v3.6.6) replacing the previous v3.6.5, indicating a backend software update rather than a content change.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows Revision: v3.6.5, indicating a software version update has been applied. This behind-the-scenes change does not affect displayed study details.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a behind-the-scenes update to the site's build. The user-facing content and layout remain unchanged.SummaryDifference0.1%

- Check85 days agoChange DetectedThe study page shows a new revision tag (v3.6.3) replacing the previous v3.6.2. This indicates a minor backend or content adjustment to the page.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the study page, indicating a backend or UI update to the page rendering. The change does not modify study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Oral Gallium Maltolate for Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Gallium Maltolate for Glioblastoma Clinical Trial page.